Literature DB >> 35273417

An Atypical Case of Miller Fisher Syndrome with Multiple Autoimmunity.

Carolina Mercado1, Mario Perez-Rueda1.   

Abstract

Miller Fisher syndrome (MFS) is a rare variant of Guillain-Barré syndrome that is characterised by ataxia, ophthalmoplegia, and areflexia. Its relation with other autoimmune diseases is scarcely found in the literature, and in those few cases, treatment has been especially difficult. We report a case of a 28-year-old woman who presented with ophthalmoplegia and ptosis, later developing facial palsy and hyporeflexia. She had positive GD1a, GT1a, GQ1b antibodies confirming MFS. She also had positive antinuclear and lupus anticoagulant antibodies confirming antiphospholipid syndrome. She had a mild clinical course. MFS can present with multiple autoimmunity; it is unclear if there is cross-reactivity due to myelin damage.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Guillain–Barré syndrome; Miller Fisher syndrome; antiphospholipid antibodies

Year:  2021        PMID: 35273417      PMCID: PMC8903788          DOI: 10.1080/01658107.2021.1916045

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  18 in total

1.  Atypical clinical manifestations of Miller Fisher syndrome.

Authors:  Jae Ho Jung; Eun Hye Oh; Jin-Hong Shin; Dae-Seong Kim; Seo-Young Choi; Kwang-Dong Choi; Jae-Hwan Choi
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

2.  [A case of atypical Miller Fisher syndrome associated with antiphospholipid antibodies].

Authors:  S Ishida; M Ura; K Kameoka; K Furukawa; M Tagami
Journal:  Rinsho Shinkeigaku       Date:  1999-04

3.  Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

Authors:  M Labrador-Horrillo; F Martinez-Valle; E Gallardo; R Rojas-Garcia; J Ordi-Ros; M Vilardell
Journal:  Lupus       Date:  2012-02-09       Impact factor: 2.911

4.  Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study.

Authors:  Maryam Sahebari; Maryam Rastin; Reza Boostani; Mohsen Forughipour; Kamila Hashemzadeh; Samira H Sadeghi
Journal:  Curr Rheumatol Rev       Date:  2019

Review 5.  Miller Fisher's syndrome.

Authors:  James W Teener
Journal:  Semin Neurol       Date:  2013-05-15       Impact factor: 3.420

6.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

7.  Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic?

Authors:  B Gilburd; M Stein; Y Tomer; D Tanne; O Abramski; Y Chapman; A Ahiron; M Blank; Y Shoenfeld
Journal:  Autoimmunity       Date:  1993       Impact factor: 2.815

8.  Neurology and the lupus anticoagulant.

Authors:  H Englert; G Derue; G R Hughes
Journal:  Eur Neurol       Date:  1985       Impact factor: 1.710

9.  Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?

Authors:  Ioannis E Dagklis; Sotirios Papagiannopoulos; Varvara Theodoridou; Dimitrios Kazis; Ourania Argyropoulou; Sevasti Bostantjopoulou
Journal:  Case Rep Neurol Med       Date:  2016-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.